Ken Warrington
Vermogen: 22 361 $ op 30-06-2026
Vermogen: 22 361 $ op 30-06-2026
Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-09-2025 | 6.776 ( 0,04% ) | 22 361 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSTEM TECHNOLOGIES, INC. | Directeur/Bestuurslid | 01-03-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | Corporate Officer/Principal | 01-12-2021 |
Biostem Life Sciences, Inc. | Operationeel Directeur | 01-05-2020 |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Hoofd Techniek/Wetenschap/O&O | 01-05-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioStem Technologies, Inc.
BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
The St. Lawrence College
The St. Lawrence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | |
Biostem Life Sciences, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau